AlphaGrep UK Ltd’s Xylem XYL Stock Holding History

AlphaGrep UK Ltd’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.03M	Buy	8,588 +1,953	+29%	+$256K	0.3%	23
2025 Q4	$904K	Buy	+6,635	New	+$954K	0.3%	44

Other funds holding XYL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

AlphaGrep UK Ltd's XYL Position: Q1 2026 in Review

AlphaGrep UK Ltd increased its Xylem (XYL) stake by 29% in Q1 2026, buying an estimated $256K and bringing the position to 8,588 shares worth $1.03M. The position accounts for 0.3% of the portfolio, ranked #23.

AlphaGrep UK Ltd first reported a position in XYL in Q4 2025 and has held it in 2 quarters since. 1,110 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

AlphaGrep UK Ltd held 8,588 shares of Xylem worth $1.03M as of Q1 2026.
AlphaGrep UK Ltd bought 1,953 Xylem shares in Q1 2026, an estimated $256K.
Xylem made up 0.3% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #23 holding.
AlphaGrep UK Ltd first reported a position in Xylem in Q4 2025 and has held it in 2 quarters since.
1,110 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.